Women's views on chemoprevention of breast cancer: qualitative study.
OBJECTIVE To determine, in a family practice setting, women's views on incentives for and
barriers to taking chemopreventive therapy for breast cancer. DESIGN Descriptive …
barriers to taking chemopreventive therapy for breast cancer. DESIGN Descriptive …
Women's decision making about whether or not to use breast cancer chemoprevention
A Altschuler, CP Somkin - Women & health, 2005 - Taylor & Francis
Background: Minimal research is available that examines how women at high risk for breast
cancer make choices about chemoprevention. We examined how women decide whether to …
cancer make choices about chemoprevention. We examined how women decide whether to …
[HTML][HTML] Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis
ME Ropka, J Keim, JT Philbrick - Journal of Clinical Oncology, 2010 - ncbi.nlm.nih.gov
Purpose Women at high risk of breast cancer face the complex decision of whether to take
tamoxifen or raloxifene for breast cancer chemoprevention. We investigated what is known …
tamoxifen or raloxifene for breast cancer chemoprevention. We investigated what is known …
Women's interest in chemoprevention for breast cancer
LA Bastian, IM Lipkus, MN Kuchibhatla… - Archives of internal …, 2001 - jamanetwork.com
Background Chemoprevention is the use of pharmacologic or natural agents to inhibit the
development of cancer. Tamoxifen citrate is the only approved chemopreventive agent for …
development of cancer. Tamoxifen citrate is the only approved chemopreventive agent for …
Chemoprevention of breast cancer: a joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering …
M Levine, JM Moutquin, R Walton, J Feightner - CMAJ, 2001 - Can Med Assoc
Objective: To assist women and their physicians in making decisions regarding the
prevention of breast cancer with tamoxifen and raloxifene. Evidence: Systematic review of …
prevention of breast cancer with tamoxifen and raloxifene. Evidence: Systematic review of …
Feasibility of a telephone survey to recruit health maintenance organization members into a tamoxifen chemoprevention trial.
M Daly, J Seay, A Balshem, C Lerman… - … , biomarkers & prevention …, 1992 - AACR
A large-scale, nationwide tamoxifen chemoprevention trial is currently being planned as a
primary preventive strategy against breast cancer. The recruitment of health asymptomatic …
primary preventive strategy against breast cancer. The recruitment of health asymptomatic …
Chemoprevention of breast cancer: a summary of the evidence for the US Preventive Services Task Force
Purpose: Chemoprevention offers promise as a strategy for reducing morbidity and mortality
from breast cancer in women. This review examined the evidence for the effectiveness of …
from breast cancer in women. This review examined the evidence for the effectiveness of …
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs
PA Fasching, G von Minckwitz, T Fischer… - Breast cancer research …, 2007 - Springer
Purpose To find associations between knowledge about risk factors for breast cancer and
the socioeconomic status of healthy women, as well as their attitude toward taking …
the socioeconomic status of healthy women, as well as their attitude toward taking …
Willingness to use tamoxifen to prevent breast cancer among diverse women
Use of chemoprevention to prevent development of breast cancer among high-risk women
has been limited despite clinical evidence of its benefit. Our goals were to determine …
has been limited despite clinical evidence of its benefit. Our goals were to determine …
[PDF][PDF] Why is breast cancer chemoprevention such a hard sell?
J Peres - 2014 - academic.oup.com
But despite the recommendation of medical authorities, including the US Preventive
Services Task Force, the American Society of Clinical Oncology, and the National Institute …
Services Task Force, the American Society of Clinical Oncology, and the National Institute …